SUMMARY In a double blind placebo controlled study the effect of calcitonin on gastric emptying and on serum concentrations of gastrin, insulin, glucose, calcium and phosphorus after a mixed solid-liquid meal was examined in eight patients with duodenal ulcer. Synthetic salmon calcitonin 415 pmol iv was given as a bolus followed by a 90 minute infusion to reach an overall dose of 62.25 pmollkg. A search for drugs effective in the treatment of peptic ulcer has continued for decades. Attention was recently focused on the anti-ulcerogenic properties of calcitonin. ' ' Doepfner and Briner' showed in an animal study that peripherally administered calcitonin inhibited gastric acid secretion and at the same time prevented formation of pentagastrin or histamine induced ulcers of the gastroduodenal region. An inhibition of the development of experimental ulcers was also shown after intracerebroventricular administration of calcitonin in rats. ' Our investigations showed that calcitonin markedly delayed gastric emptying in normal men.3 Hypersecretion of acid and an enhanced gastric emptying are believed to be involved in the pathogenesis of duodenal ulcer.' Taking into account the calcitonin effects quoted above, it could be argued that calcitonin could counteract both abnormalities. The pre- Accepted for publication 311 Septeniher 1988. sent investigations were undertaken to examine the effect of calcitonin on gastric emptying, and on the profiles of serum gastrin and insulin, as well as glucose, calcium, and phosphorus concentrations after ingestion of a mixed solid-liquid meal in patients with an active duodenal ulcer.
gastric acid secretion elicited by calcitonin warrants further studies of calcinonin in the treatment of duodenal ulcer.
A search for drugs effective in the treatment of peptic ulcer has continued for decades. Attention was recently focused on the anti-ulcerogenic properties of calcitonin. ' ' Doepfner and Briner' showed in an animal study that peripherally administered calcitonin inhibited gastric acid secretion and at the same time prevented formation of pentagastrin or histamine induced ulcers of the gastroduodenal region. An inhibition of the development of experimental ulcers was also shown after intracerebroventricular administration of calcitonin in rats. ' Our investigations showed that calcitonin markedly delayed gastric emptying in normal men.3 Hypersecretion of acid and an enhanced gastric emptying are believed to be involved in the pathogenesis of duodenal ulcer.' Taking into account the calcitonin effects quoted above, it could be argued that calcitonin could counteract both abnormalities. The pre-sent investigations were undertaken to examine the effect of calcitonin on gastric emptying, and on the profiles of serum gastrin and insulin, as well as glucose, calcium, and phosphorus concentrations after ingestion of a mixed solid-liquid meal in patients with an active duodenal ulcer.
Methods

PATIENTS
Eight male inpatients with a recent endoscopic diagnosis-that is, one established one to three days before the gastric emptying examinations-of a nonobstructing duodenal bulb ulcer participated in the study. All were habitual smokers, and smoked a median number of 15 cigarettes (range [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] 
Results
In all patients examined calcitonin consistently inhibited gastric emptying-a statistically significant delay in gastric emptying was observed already 15 minutes after the start, and continued till the end of calcitonin infusion (Fig. 1A) . The delaying effect of calcitonin on gastric emptying was reflected by a significant decrease of the emptying index, Ix: 2-979 (0.397)/min. after placebo v 0-896 (0.317)/min after calcitonin, p<0.001 (Fig. 1B) .
The basal serum gastrin concentration amounted to 36 (4.2) ng/l on the placebo day, and 39 (5.0) ng/l on the calcitonin day-a difference statistically insignificant ( Fig. 2A) . Both on the placebo and on the calcitonin day, ingestion of the test meal caused a significant increase in the serum gastrin concentration ( Fig. 2A) . The comparison of calcitonin versus placebo at 0, 30, 60, and 90 minutes revealed that the hormone did not significantly affect the postprandial release of gastrin ( Fig. 2A) . Thus the integrated gastrin response (the area under the gastrin curve, AUC(W()), although slightly lowered, did not significantly differ after calcitonin and after placebo administration: AUCO-90 8767 (880) pg/I min (placebo), and 7807 (619) pg/I min (calcitonin) (Fig. 2B) .
The basal serum insulin concentration did not significantly differ between the placebo (5.4 (0.65) mU/I) and the calcitonin (5.6 (0.54) mU/I) day (Fig.  3A) . During the placebo infusion the serum insulin concentration significantly increased postprandially -a peak concentration of 37-5 (5.73) mU/I was observed at 30 minutes after ingestion of the meal, and thereafter the serum insulin level decreased (Fig. 3A) . The postprandial release of insulin was abolished during calcitonin infusion as no significant rise above the basal serum insulin concentration was observed (Fig. 3A) . Consequently, the integrated insulin response was significantly suppressed after calcitonin when compared with the placebo infusion:
area under the insulin curve, AUC-9(, 2258 (242) mU/l min after placebo v 736 (131) mU/l min after calcitonin, p<0001 (Fig. 3B ).
Similar basal serum glucose concentrations were found on the placebo (3.9 (0.09) mmol/l) and on the calcitonin (4.0 (0.13) mmol/l) day (Fig. 4) . During the placebo infusion the serum glucose rose to a peak concentration of 5-4 (0.45) mmolAl at 30 minutes after the test meal, and subsequently the serum glucose concentration decreased (Fig. 4) . On the other hand, the serum glucose concentration steadily increased during calcitonin infusion, and statistically significant differences versus placebo were found at 60 (p<0.05) and 90 (p<002) minutes postprandially (Fig. 4) .
No significant effect of calcitonin on serum concentrations of calcium or phosphorus was observed throughout the infusion when compared to the placebo situation (Fig. 5) .
None of the patients reported any adverse effects during the examinations.
Discussion
According to Hotz et al'3 an intravenous dose of about 41.5 pmol/min calcitonin was required to diminish gastric acid secretion in man by 50%. The calcitonin dose examined in the present study provided an infusion rate of 43-8 pmol/min in a subject weighing 70 kg. At the same time the overall administered in the present investigations calcitonin dose (62.25 pmol/kg body mass) corresponded to an average pharmacological dose recommended for repetitive administration during a prolonged treatment in man. '4 It is worth noting that a dose of calcitonin which would be expected to bring about a 50% inhibition of pentagastrin stimulated gastric acid secretion in man'3 elicited a pronounced delaying effect on gastric emptying in the patients examined. As taking into account the physiological regulatory mechanisms, an acceleration of gastric emptying would be expected to occur in response to the reduction of the acid load reaching the duodenum.9 It, According to some former studies, calcitonin would be expected to decrease gastrin release. ' 
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The lack of a significant inhibitory effect of calcitonin on the postprandial gastrin release, as observed in the present study, however, can be explained by the calcitonin evoked suppression of gastric emptying. Because retention of food within the stomach would elicit an augmented and prolonged gastrin release.'6 Consequently, the calcitonin suppressive effect on gastrin release might be counterbalanced by a simultaneous promotion of gastrin secretion evoked secondary to the calcitonin inhibition of gastric emptying.
The results of this study indicate that suppression of the postprandial insulin release by calcitonin would be only partially explained by calcitonin inhibition of the pancreatic endocrine function.'`A factor contributing to the abolishment of release of insulin postprandially is the calcitonin evoked inhibition of gastric emptying due to which smaller amounts of food passed into the intestine. It should be pointed out that as far as serum glucose concentration is concerned, a delaying effect of calcitonin on gastric emptying reduced the sequleae of simultaneously observed impairment of insulin release.
The results obtained indicate that calcitonin effects on the digestive tract reported here were unrelated to extracellular calcium or phosphorus concentrations. One cannot, however, exclude a possibility that calcitonin affected the intracellular distribution of calcium.`T he present investigations showed that apart from inhibition of gastric acid secretion described by others,' calcitonin markedly delayed gastric emptying in duodenal ulcer patients. Because an abnormally increased gastric emptying is met in a large subgroup of patients with an active ulcer,' it is logical to suppose that calcitonin inhibition of gastric emptying could add to ulcer healing. As calcitonin is resistant to acid and can be administered orally,'" the idea of calcitonin treatment of duodenal ulcer seems to be promising and therefore a prompt performance of controlled trials should be encouraged. 
